Mectacer Biolox R Delta Femoral Heads
Medacta International
FDA Clearance Information
The Mectacer BIOLOX R Delta Femoral Heads were cleared through the FDA 510(k) pathway on October 7, 2011. Manufactured by Medacta International, this device is classified as a Class 2 medical device under product code LZO.
What It Is
FDA-Cleared Indications
- Use in total hip arthroplasty for patients who require replacement of the femoral head and acetabular joint surfaces because of degenerative or traumatic joint disease.
- Use with compatible Medacta hip system components according to the applicable device labeling and surgical technique.
Clinical Applications
- Ceramic femoral-head replacement during primary total hip arthroplasty.
- Treatment of end-stage hip joint disease when total hip replacement is indicated.
- Use with a compatible acetabular component as part of a total hip implant system.
- Reconstruction of the femoral side of the hip joint using an appropriately sized ceramic head.
Practical Considerations
- The femoral head must be matched to a compatible femoral stem taper, acetabular component, head diameter, and neck length listed in the applicable labeling.
- Available sizes and configurations should be selected to restore hip biomechanics and accommodate the patient's anatomy.
- Ceramic components require careful handling; scratching, contamination, improper assembly, or damage to the taper can increase the risk of fracture or implant failure.
- The implant is intended for use by orthopedic surgeons familiar with total hip arthroplasty and the relevant surgical technique.
- MRI safety depends on the complete hip implant system and its metallic components. The specific implant labeling and current MRI conditions should be reviewed before scanning.
Related Literature
Frequently Asked Questions
What is Mectacer BIOLOX R Delta Femoral Heads used for?
They are used in total hip replacement surgeries to provide a durable, low-wear articulation surface.
What specialties typically use this device?
Orthopedic surgeons specializing in joint replacement and hip arthroplasty use this device.
What are the FDA-cleared indications?
The device is indicated for use in patients needing hip replacement due to degenerative joint diseases like osteoarthritis and rheumatoid arthritis.